Continuing Education Schedule

1:00 pm
ANNUAL IMMUNIZATION UPDATE: 2022
Richard Dang, PharmD, APh, BCACP, FCPhA

Click for Description & Learning Objectives

Description: Beyond COVID-19 vaccines: An up-to-date knowledge of CDC immunization recommendations is essential for pharmacists initiating and administering vaccines in California. This program will focus on key changes to the CDC’s annual immunization schedules and new vaccine products approved in the last 2 years. Since 2020, the FDA has approved a number of new and novel vaccine products, such as vaccines for tick-borne encephalitis, hepatitis B, pneumococcal, meningococcal, dengue fever, ebola, and COVID-19. Additionally, the CDC ACIP has updates its recommendations for the use of hepatitis B, pneumococcal, Tdap, HPV, and zoster vaccines. Patient cases will highlight updates to these recommendations for routine use in adult and pediatric populations.

Learning Objectives:
1. Identify appropriate resources for immunization recommendations.
2. Review and interpret important changes to ACIP recommendations and the CDC’s immunization schedules for adults and children in the United States.
3. Review newly licensed vaccine products and examine data on efficacy and safety.
4. Examine information about the efficacy and safety of newly licensed vaccine products.
5. Review patient profiles and recommend immunizations based on age, medical indications, or other risk factors.

1.0 CE Hour 0113-0000-22-015-L06-P; 0113-0000-22-015-L06-T
1:00 pm
REFLECT, RECOMMIT, AND REENGERIZE YOUR LIFE!
Jennifer Courtney PharmD, BS; Sona Frausto, PharmD, MA, FCPhA

Click for Description & Learning Objectives

Description: Are you looking for a different way to practice? Have you thought about changing your perspective? What can you change versus what you cannot change? Need help managing the mayhem and reconnecting with your profession? Pharmacists are the most accessible healthcare provider and an essential part of the front-line healthcare team, especially during the COVID-19 pandemic. Pharmacy practice has turned into quotas, staffing shortages, burnout, which can lead to sacrificing personal care and patient care. We need to learn or redevelop strategies to be successful in our high performing jobs, and even under the extreme pressure that we are under, we can still find time to connect with the people around us and learn to look at them again not as a barrier to doing our job, but as the reason we chose this profession. We need to remind ourselves that we are saving lives and give ourselves permission to slow down to assure accuracy and great patient care for our patients.

Learning Objectives:
1. Recall the reasons why we got into the pharmacy profession.
2. Review your role as a pharmacist and essential healthcare professional.
3. Identify opportunities to reestablish soft skills in your everyday pharmacy practice.
4. Identify limitations of your day-to-day practice and maneuver through them to preserve your personal care.
5. Describe ways to balance work responsibilities with your mental health and decrease burnout.

1.0 CE Hour 0113-0000-22-023-L04-P; 0113-0000-22-023-L04-T
1:00 pm
RELEVANCE OF KNOWLEDGE IN HOMEOPATHIC MEDICINE IN PHARMACY PRACTICE
Swathi Varanasi, PharmD

Click for Description & Learning Objectives

Description: You can find homeopathic medicines in most pharmacies across the U.S. But, what are they and how can they help our patients? In order to provide the best possible counseling tips and avoid the misuse of these FDA-regulated drugs, pharmacists should know about homeopathy. This program presents an introduction to the regulatory, manufacturing, safety, and efficacy of homeopathic medicines, as well as practical case studies to help us, as pharmacists, make a difference in patient’s care.

Learning Objectives:
1. Identify the main characteristics of homeopathic medicines.
2. Recognize the clinical implications of homeopathic manufacturing.
3. Classify the benefit/risk ratio of OTC homeopathic medicines.
4. Answer main questions from patients about homeopathic medicines.

1.0 CE Hour 0113-0000-22-011-L01-P; 0113-0000-22-011-L01-T
1:00 pm
NETWORKING 101: ENGAGEMENT WITH THE PHARMACY PROFESSION VIRTUAL/ON-DEMAND ONLY - Student Program
Laressa Bethishou, PharmD, APh, BCPS

Click for Description

Description: This interactive session will describe how professional engagement can empower pharmacists and advance the profession. Learners will explore why engagement matters, review different organizations and how to select one that aligns with personal and professional goals, and discuss strategies for engagement and effective networking through professional engagement at the local, state, and national levels.

2:30 pm
DO YOU KNOW HOW TO CODE SWITCH?
Debrina Johnson, PharmD

Click for Description & Learning Objectives

Description: Do you code switch with your patients? What is Code Switching? How does it provide a better means of communication with your patients? You probably already do it in this session you’ll find out how to utilize communication techniques to show cultural humility and improve patient care.

Learning Objectives:
1. Define cultural humility and how it relates to patient care.
2. Discuss the various communication techniques to improve patient care.
3. Identify and dispel myths about communication including language barriers.
4. Describe some of the current research surrounding cultural humility and communication.

1.0 CE Hour 0113-0000-22-016-L04-P; 0113-0000-22-016-L04-T
2:30 pm
IMPLEMENTATION OF CLINICAL SERVICES IN A SPECIALTY PHARMACY
Havan Truong, PharmD, CSP; Roslynn Stone, PharmD, PhD

Click for Description & Learning Objectives

Description: Specialty medications are high-cost, high-touch medications that oftentimes require additional care and monitoring to ensure safe usage. Each year, as more specialty medications get approved for self-administration, the need for optimizing patient care in the outpatient setting expands. As such, specialty pharmacy has become a fast growing field in pharmacy practice. This presentation will present and review unique clinical services that can be implemented in a specialty pharmacy setting.

Learning Objectives:
1. Describe an academic health center-based specialty pharmacy.
2. Explain gaps in patient care with specialty medications.
3. Discuss clinical services that can be integrated to specialty pharmacy workflow.
4. Classify barriers of implementation of clinical services.

1.0 CE Hour 0113-0000-22-022-L04-P; 0113-0000-22-022-L04-T
2:30 pm
UNPACKING OUR COVID-19 TRAVEL RECOMMENDATIONS
Leah Amirian, PharmD; Jeffrey Goad, PharmD, MPH, FISTM, FAPHA, FCSHP, FCPhA; Megan Matthews, PharmD

Click for Description & Learning Objectives

Description: The COVID-19 pandemic has reshaped how people view travel. While some are anxious to get back out there and explore, others are cautious about international regulations and protection against infection. Prior to the most recent pandemic, pharmacists in Travel Health have provided an efficient and convenient platform for travelers to prepare for any health-related needs prior to take-off. As the world begins to open back up, we are expecting a substantial wave of international travel, and patients have a lot of questions about how to do this safely – Where are the safest travel destinations? What are the requirements for proving vaccination status? Should I get tested for COVID-19 prior to leaving the US or once I arrive at my destination? As the pharmacist, do you have the answers?

Learning Objectives:
1. Describe the current COVID-19 global epidemiology and its impact on international COVID-19 entry/exit requirements.
2. Discuss common travel-related vaccine preventable diseases, including COVID-19 vaccines here and abroad, for various types of travelers.
3. List recommendations for safe travel during the COVID-19 pandemic.

1.0 CE Hour 0113-0000-22-003-L01-P; 0113-0000-22-003-L01-T
8:00 am
DIABETES AN EVER-CHANGING LANDSCAPE
Marina Dykhne PharmD, BCACP, APh, CDCES; Nicole Nielsen, PharmD, BCACP, APh, MEHP

Click for Description & Learning Objectives

Description: This program is designed for pharmacists practicing in a variety of settings and managing patients with uncontrolled diabetes. This presentation addresses novel treatment options and newly updated ADA, AACE and KDIGO guidelines as well as new indications for existing hyperglycemic therapeutics. This educational activity will enable pharmacists develop rational therapeutic recommendations to various patients with diabetes utilizing treatment guidelines to maximize patient specific outcomes.

Learning Objectives:
1. Review current ADA, AACE, KDIGO guidelines for treating patients with type 2 diabetes.
2. Identify the efficacy, safety, and impact of various classes of antihyperglycemic agents in reducing micro- and macrovascular disease and nephropathy.
3. Discuss the importance of appropriate medication selection for patient medication adherence.
4. Review evolving landscape of diabetes management and beyond.

1.0 CE Hour 0113-0000-22-014-L01-P
8:00 am
REGULATORY REVIEW FOR COMPOUNDING IN CALIFORNIA
Christine Acosta PharmD, Supervising Inspector, CA Board of Pharmacy; Tony Park, PharmD, J.D., Principal Attorney, California Pharmacy Lawyers

Click for Learning Objectives

Learning Objectives:
1. Describe general State and Federal laws that govern the practice of pharmaceutical compounding.
2. Explain the overarching trends in the regulatory climate for California compounding pharmacists.
3. Review current pharmacy standards of practice in compounding.
4. Identify common mistakes related to various aspects of compounding.

1.0 CE Hour 0113-0000-22-027-L07-P; 0113-0000-22-027-L07-T
8:00 am
STRATEGIES TO HELP ADDRESS AND PREVENT PROFESSIONAL BURNOUT
Michael Negrete, PharmD; Nancy Alvarez, PharmD, BCPS, FAPhA

Click for Description & Learning Objectives

Description: According to the National Academy of Medicine, clinicians of all kinds, across all specialties and care settings, are experiencing alarming rates of burnout, which can lead to serious, wide-ranging consequences on individual clinicians, health care organizations, and patient care. In this session, participants will learn about the common signs of burnout and be introduced to a framework for understanding and using their personal values, interests, strengths and needs to prevent burnout, or at least combat its harmful effects.

Learning Objectives:
1. Identify personal levels of fatigue, depression, anxiety/stress, and mental/physical wellbeing.
2. Identify at least two activities which:
· Generate a sense of personal purpose and meaning.
· Leverage their unique combination of personal strengths and abilities.
· Stimulate their drive for a persistent pursuit towards the achievement of mastery, and/or.
· Enhance resilience through supporting personal health and wellbeing.
3. Discuss the importance of ""community"" in preventing/addressing burnout.

1.0 CE Hour 0113-0000-22-019-L04-P; 0113-0000-22-019-L04-T
8:00 am
EMOTIONAL INTELLIGENCE: MASTERING YOUR INTERPERSONAL SKILLS - Student Program
Peter Tenerelli, BS, PharmD, EMP

Click for Description

Description: Presentation will define Emotional Intelligence is, why it is important both personally and professionally, review its four critical domains, and teach students how they can develop their Emotional Intelligence for future success.

10:30 am
2022 NEW PHARMACY LAWS UPDATES
Anne Sodergren, Executive Officer, CA Board of Pharmacy; Tony Park, PharmD, J.D., Principal Attorney, California Pharmacy Lawyers

Click for Learning Objectives

Learning Objectives:
1. Describe the changes in State and Federal Laws for 2022.
2. Review overarching trends in the regulatory climate for California pharmacists.
3. Explain some of the current pharmacy standards of practice.
4. Identify resources for staying current on changing regulatory issues.

1.0 CE Hour 0113-0000-22-028-L03-P; 0113-0000-22-028-L03-T
10:30 am
COMMUNICATING WITH EMPATHY IN PATIENT CARE INTERACTIONS VIRTUAL/ON-DEMAND ONLY
Laressa Bethishou, PharmD, APh, BCPS; Luma Munjy, PharmD

Click for Description & Learning Objectives

Description: This interactive session will utilize case discussions and role play to describe the importance of empathy in providing effective patient care, discuss empathetic listening and communication with empathy in patient interactions, and describe and address empathy burnout in healthcare providers.

Learning Objectives:
1. Describe the importance of empathy in providing effective patient care.
2. Discuss strategies for empathetic listening and communication with empathy in patient interactions.
3. Describe and address empathy burnout in healthcare providers.

1.0 CE Hour 0113-0000-22-009-L04-P; 0113-0000-22-009-L04-T
10:30 am
THE INFLUENCE OF NUTRIENTS, FOOD AND THE INTESTINAL MICROBIOTA ON DEPRESSION – IT’S A FULL HOUSE
Cynthia Lieu, PharmD, BCNSP

Click for Description & Learning Objectives

Description: Nutritional psychiatry is a growing field that focuses on the role of nutrition in the development and treatment of mental health conditions. What changes can be made to the nutritional intake of an individual to reduce symptoms of depression? What is the relationship between the intestinal microbiota and depression?

Learning Objectives:
1. Discuss how consumption of specific nutrients may positively or negatively affect depression.
2. Discuss how consumption of specific foods may positively or negatively affect depression.
3. Discuss the possible relationship between the intestinal microbiota and depression.

1.0 CE Hour 0113-0000-22-020-L01-P; 0113-0000-22-020-L01-T
10:30 am
THE THREE IN ONE APPROACH: CONSIDERATIONS FOR USING SINGLE-INHALER TRIPLE THERAPY IN PATIENTS WITH COPD
Marina Dykhne PharmD, BCACP, APh, CDCES; Sarah McBane, PharmD, CDCES, BCPS, FCCP, FCPA, APh

Click for Description & Learning Objectives

Description: This program is designed for pharmacists managing patients with COPD in variety of settings. More patients are being prescribed several inhaled medications to treat their COPD. This session will enable pharmacists to optimize use of single-inhaler triple therapy as part of a COPD regimen.

Learning Objectives:
1. Review current COPD pharmacotherapy recommendations.
2. Discuss key studies evaluating single-inhaler triple therapy.
3. Identify the efficacy, safety, and impact of triple therapy .
4. Discuss important considerations in selecting a single-inhaler triple therapy regimen.

1.0 CE Hour 0113-0000-22-012-L01-P
10:30 am
CAREER ROUNDTABLE - Student Program
Melissa Kimura, PharmD; Vivian Truong, PharmD

Click for Description

Description: Come meet and network in a roundtable setting with pharmacists in multiple different career settings. Learn about their path to both typical and atypical careers in settings like industry, hospital, education, law, consulting and much more.

4:30 pm
COMPREHENSIVE MEDICATION MANAGEMENT TEAM-BASED CARDIOMETABOLIC CARE
Alex Luli, PharmD, BCACP; Nathan Painter, PharmD, CDCES, FADCES

Click for Description & Learning Objectives

Description: This session will present the foundational overview of comprehensive medication management and the role of the pharmacist in diabetes care and education. Participants will practice utilizing team-based comprehensive medication management with cardiometabolic conditions in case scenarios.

Learning Objectives:
1. Describe an overview of comprehensive medication management.
2. Identify and address cardiometabolic needs of people with diabetes using comprehensive medication management.
3. Explain comprehensive medication management for people with diabetes in a primary care setting using a team-based approach.

1.0 CE Hour 0113-0000-22-007-L01-P; 0113-0000-22-007-L01-T
4:30 pm
GROWING PAINS – HOW WE CAN CONTINUE TO MANAGE PAIN WITH NON-OPIOID THERAPIES
Allison Chacon PharmD; Melissa Durham, PharmD, MACM

Click for Description & Learning Objectives

Description: The opioid epidemic has been running rampant since the late 1990s, and there have been multiple attempts to try and decrease the opioid burden in the United States. Pharmacists are the health care professionals who are the most easily accessible to all of our patients, and we can provide a crucial role in helping these patients manage their pain in various ways. This session will review the various non-opioid alternate therapies to help these patients manage their pain. We will work to provide pharmacists the confidence to recommend these alternate therapies and answer any questions that these patients have can be a crucial step to their success on tapering off of opioids and onto safer medications.

Learning Objectives:
1. Outline recent trends in opioid use and the various strategies that have been used to decrease opioid use.
2. Discuss the common pain conditions and their standard treatment options.
3. Describe the non-opioid alternate therapies that can be used for various conditions.
4. Explain various scenarios where non-opioid medications can be used.

1.0 CE Hour 0113-0000-22-005-L08-P; 0113-0000-22-005-L08-T
4:30 pm
LEADERSHIP - THAT'S NOT MY JOB!
Brian Kawahara, PharmD; Nancy Alvarez, PharmD, BCPS, FAPhA

Click for Description & Learning Objectives

Description: Pharmacists are expected to meet patient care and productivity demands often in the absence of someone with authority (i.e., director or manager). Pharmacy technicians are expected to meet productivity demands in support of the work of pharmacists and pharmacy interns. Each can exhibit leader attitudes and behaviors, particularly when a team needs to be lead and irrespective of position. When this need occurs, how do you respond? Too often, the sentiment is, “That’s not my job!” This interactive session will explore why it is important that you take charge and lead, and will help you prepare for situations where you find yourself suddenly required to lead through the discovery of skills and strategies needed to be effective leaders.

Learning Objectives:
1. Describe the differences between positional leadership and personal leadership.
2. Explain how behavioral styles can help or hinder the team.
3. Discuss the importance of trust and why it is important when leading a team when you are not the positional leader.
4. Explain why good communications is essential to leading a team.
5. xplain the difference between motivation and inspiration and which is leader dependent.

1.0 CE Hour 0113-0000-22-025-L04-P; 0113-0000-22-025-L04-T
4:30 pm
LGBTQ HEALTHCARE AND THE ROLE OF THE PHARMACIST: PROVIDING GENDER AFFIRMING CARE ACROSS YOUR PRACTICE VIRTUAL/ON-DEMAND ONLY
Michelle Sherman RPh, APh, FASCP, FACA, AAHIVP

Click for Description & Learning Objectives

Description: This presentation addresses challenges in LGBTQ Healthcare in accessing care in the pharmacy setting in the Face of a triad of pandemics. Pharmacists play a crucial role in breaking through stigma and myths, providing safe, culturally competent care that improve patient outcomes and quality of life.

Learning Objectives:
1. Identify gaps in LGBTQ Healthcare and how pharmacists can make a difference.
2. Explain the role of the pharmacist in impacting positive health outcomes in LGBTQ community.
3. Identify barriers to equitable healthcare in LGBTQ community.
4. Discuss PrEP and PEP and impact pharmacists can have in ending HIV epidemic.
5. Describe changes in your practice that would be implemented to be LGBTQ competent and practice with cultural humility.

1.0 CE Hour 0113-0000-22-017-L04-P
9:30 am
LET'S TRIM THE FAT: HOW TO INCORPORATE LEAN INTO YOUR PHARMACY PRACTICE
Jason Lam, PharmD, CSSBB, FCPhA, FCSHP

Click for Description & Learning Objectives

Description: This presentation will provide pharmacists, technicians, and students with a historical summary of Lean and an introduction to the five Lean Principles. We will then interact and familiarize ourselves with the following Lean tools: waste walk/8 types of waste, value stream map, determination of in-process and outcome metrics. The session goal is to provide the audience with turnkey tools they can use to improve processes in all pharmacy practice settings.

Learning Objectives:
1. Define and list examples of the 8 types of waste.
2. Arrange a value stream map for a process in your pharmacy practice setting.
3. Explain the difference between value and non-value added process steps from the customer’s perspective.
4. Identify meaningful in-process and outcome measures for your pharmacy practice setting.

1.0 CE Hour 0113-0000-22-004-L04-P; 0113-0000-22-004-L04-T
9:30 am
TRAUMATIC COMBAT CASULTY CARE
Clifford Young RPh, CGP, FCPhA, FAWM; Randy Nguyen, CPhA Student Trustee

Click for Description & Learning Objectives

Description: Develop leadership skills and the mental blueprint to handle potential severe medical trauma in the Platinum Ten Minutes - motor vehicle accidents, public gatherings, household accidents. Formal and improvised solutions to medical trauma following the MARCH protocol for Traumatic Casualty Care (TCCC).

Learning Objectives:
1. Explain how the MARCH protocol can provide definitive care until the patient can be transported to a higher level of care.
2. Identify differences and similarities of different methods to stop moderate to severe hemorrhaging.
3. List ways to ensure a patent airway, and address pneumothorax.
4. List options for improvised trauma care in austere environments.
5. Name methods and materials to have for personal medical kits on the body, in the car, and at home to prepare for emergencies when time is of the essence and traditional first responders are delayed.

1.0 CE Hour 0113-0000-22-024-L05-P; 0113-0000-22-024-L05-T
9:30 am
UPDATES IN GLAUCOMA TREATMENTS
Martin Torres, PharmD; Emily Stephey, OD

Click for Learning Objectives

Learning Objectives:
1. Explain the pathophysiology of elevated intraocular pressure.
2. Describe the criteria used to make a diagnosis of glaucoma and initiate pharmacotherapy.
3. Identify the various classes of medications utilized in the treatment of elevated intraocular pressure or glaucoma.
4. List and compare the different mechanisms of action for the medication classes prescribed to treat elevated intraocular pressure or glaucoma.
5. Describe common side effects and relative contraindications of topical glaucoma medications.
6. Identify the role of a pharmacist in providing medication education in the treatment of glaucoma.

1.0 CE Hour 0113-0000-22-021-L01-P; 0113-0000-22-021-L01-T
9:30 am
YOU ARE ENOUGH! - Student Program
TJ Watkins

Click for Description

Description: We are all born with a default inner dialogue setting that we are not enough or that there is something missing or wrong with us. In this seminar we explore the mechanism that the mind uses to reinforce this universal experience. This talk offers you practical strategies to shift from feeling not enough to tap into your innate immeasurable self value, wholeness and completeness, now.

IMPLEMENTING DIVERSITY EQUITY AND INCLUSION (DEI) INITIATIVES IN COMMUNITY PHARMACIES: A WORKSHOP
Cheryl Wisseh, PharmD, MPH; Jeremy Dow, PharmD; Melissa Durham, PharmD, MACM

Click for Description & Learning Objectives

Description: Diversity, Equity, and Inclusion (DEI) has recently become a large focus for many schools of pharmacy, yet implementation outside of academic setting is not commonly practiced. In community pharmacies, DEI initiatives can help pharmacists better engage with patients and in turn, improve patient outcomes. Are you prepared for the future of healthcare where pharmacists must address patients’ needs that may be rooted in their racial/ethnic identity, gender/sexual identity, and overall socioeconomic status? Creating DEI initiatives that support patients at your pharmacy will allow you to continue to be an integral service in the community. This program will highlight methods to integrate DEI in a community pharmacy and guide pharmacists in the planning and implementation process at their own locations.

Learning Objectives:
1. Describe Diversity Equity, and Inclusion (DEI) in the workplace and the benefits of implementation.
2. Identify and explain current DEI initiatives commonly seen in healthcare settings.
3. Review an aspect of community pharmacy where DEI can be incorporated.
4. Arrange a personalized outline for implementing DEI in a pharmacy.
5. Review patient profiles and recommend immunizations based on age, medical indications, or other risk factors.

1.0 CE Hour 0113-0000-22-018-H04-P; 0113-0000-22-018-H04-T
RHEUMATOLOGY GUIDELINE AND TREATMENT UPDATE 2021
Allison Chacon PharmD; Janet Cho, PharmD; Daniel Arkfeld, MD

Click for Description & Learning Objectives

Description: In the world of rheumatology, it seems that every few months there is a new medication that comes out for various rheumatologic conditions, such as lupus nephritis or rheumatoid arthritis. As pharmacists, patients have a lot of questions on these new medications and whether or not it might be appropriate for them to take, and they look to us for some of these answers. This session will provide an update on the new American College of Rheumatology (ACR) Guidelines for 2021, highlight some of the more recent medications that have just been approved over the last year and discuss updated FDA warnings on JAK inhibitors that may affect our patients.

Learning Objectives:
1. Review the changes to the 2021 ACR Guidelines.
2. Discuss the common rheumatology conditions and their standard treatment options.
3. Describe the newly approved treatment options used in rheumatology.
4. Explain the new FDA warnings for JAK inhibitors.

1.0 CE Hour 0113-0000-22-006-H01-P; 0113-0000-22-006-H01-T
TOBACCO CESSATION PROGRAMS IN A POST-COVID WORLD
Edwin Shamtob, PharmD; Katty Hsu PharmD APh; Whitney Fakolade, PharmD

Click for Description & Learning Objectives

Description: It is a known fact that people with certain medical conditions are at risk of developing severe COVID-19 disease, including current or former smokers. As the need for tobacco cessation programs increase due to the evolving type of tobacco products available to the general population, it is important as clinicians to assess our patient’s willingness to quit tobacco products by providing additional resources and information on tobacco cessation, along with patient care plans backed by current guidelines and recommendation. This program will provide guidelines and recommendations on tobacco cessation in a post-COVID world, along with additional resources and information to assists patients to being tobacco free.

Learning Objectives:
1. Review the current guidelines for tobacco cessation.
2. Identify new products, such as FDA-approved e-cigarettes and discuss their role in tobacco cessation programs.
3. Identify and discuss the role of vaping in tobacco cessation programs.
4. Review informational resources to help patients with tobacco cessation.
5. Describe helpful tips and tricks to share with patient’s/healthcare professionals in conjunction with tobacco cessation.

1.0 CE Hour 0113-0000-22-013-H01-P; 0113-0000-22-013-H01-T
THE IMPACT OF COVID-19
Diem Thai, PharmD

Click for Description & Learning Objectives

Description: This session will retrospectively examine the impact of Covid-19. More specifically, looking at vaccinations, infection rates, hospitalization, and deaths locally, nationally, and internationally. Understanding the impact of Covid-19 on healthcare in terms of responses to the crisis can lead to informed and better clinical decision making.

Learning Objectives:
1. Describe the prevalence and severity of COVID-19 locally, nationally, and internationally.
2. Discuss national and international response to COVID-19.
3. Discuss the impact of COVID-19 on healthcare.

1.0 CE Hour 0113-0000-22-010-H01-P; 0113-0000-22-010-H01-T
UPDATES IN ANTIPLATELET THERAPY FOR SECONDARY PREVENTION OF STROKE
Laura Tsu, PharmD, BCPS, BCGP, BCCP; Viet-Huong Nguyen, PharmD, MPH, MSc

Click for Description & Learning Objectives

Description: Balancing the risks and benefits of antiplatelet medications in patients after an ischemic stroke is imperative to decrease the risk of recurrent stroke as well as bleeding complications. There continues to be clinical controversies regarding which population dual antiplatelet therapy is optimal for as well as when and for how long to use dual antiplatelet therapy for recurrent stroke prevention. This interactive, case-based session will present updated clinical studies and recommendations, as well as incorporate active learning to discuss risk/benefit assessments about pharmacological treatment and management. This information pertains to pharmacists in all pharmacy practice settings, including ambulatory, long-term, community, and hospital settings.

Learning Objectives:
1. List risk factors for non-cardioembolic stroke.
2. Discuss the differences and similarities of antiplatelet options in patients with ischemic stroke.
3. Discuss the optimal duration of dual antiplatelet therapy post-stroke.
4. Arrange a patient care plan for antiplatelet therapy for secondary stroke prevention, including medication selection, monitoring, and education.

1.0 CE Hour 0113-0000-22-008-H01-P; 0113-0000-22-008-H01-T
JOURNEY TO COMMUNITY-BASED PHARMACY RESIDENCY - Student Program
Diane La PharmD; Diana Arouchanova, PharmD; Helena Mahsaradjian, PharmD; William Lu, PharmD, APh, BCPS

Click for Description

Description: Student pharmacists are often not informed or aware what postgraduate year 1 (PGY1) community-based pharmacy residency is. This presentation is intended to inform the public what this residency is and its components. During this presentation we will also discuss how community-based pharmacy residency is different from general pharmacy residencies and ambulatory care residencies. This information regarding a variety of first year residency programs will allow student pharmacists to make educated choices on what programs they would like to pursue to reach their career goal.